TransDigm Group Reports Fiscal 2022 Fourth Quarter And Year-End Results
Fourth quarter highlights include:
- Net sales of
$1,510 million , up 18% from$1,279 million in the prior year's quarter; - Income from continuing operations of
$266 million , up 27% from$209 million in the prior year's quarter; - Earnings per share from continuing operations of
$3.98 , up 11% from$3.58 in the prior year's quarter; - EBITDA As Defined of
$752 million , up 18% from$636 million in the prior year's quarter; and - Adjusted earnings per share of
$5.50 , up 29% from$4.25 in the prior year's quarter.
Fiscal 2022 highlights include:
- Net sales of
$5,429 million , up 13% from$4,798 million in the prior fiscal year; - Income from continuing operations of
$866 million , up 27% from$681 million in the prior fiscal year; - Earnings per share from continuing operations of
$13.38 , up 29% from$10.41 in the prior fiscal year; - EBITDA As Defined of
$2,646 million , up 21% from$2,189 million in the prior fiscal year; - EBITDA As Defined margin of 48.7%, up 310 basis points from the prior fiscal year; and
- Adjusted earnings per share of
$17.14 , up 41% from$12.13 in the prior fiscal year.
This quarter,
Quarter-to-Date Results
Net sales for the quarter increased 18.1%, or
Income from continuing operations for the quarter increased
GAAP earnings per share were reduced in the quarter by
Adjusted net income for the quarter increased 26.2% to
EBITDA for the quarter increased 14.8% to
Year-to-Date Results
Fiscal 2022 net sales increased 13.2%, or
Fiscal 2022 income from continuing operations increased
GAAP earnings per share were reduced in fiscal 2022 and 2021 by
Fiscal 2022 adjusted net income increased 41.0% to
Fiscal 2022 EBITDA increased 21.2% to
During fiscal 2022,
"I am very pleased with our team's performance and the overall operating results for the fourth quarter and full fiscal year 2022," stated
During fiscal 2022, we remained sharply focused on our value drivers and cost structure. This strict operational focus together with the continued recovery of our commercial aftermarket revenues drove a strong fiscal 2022 EBITDA As Defined margin of 48.7%, which was up over three margin points from the prior year.
We are pleased to have deployed approximately
Please see the attached tables for a reconciliation of income from continuing operations to EBITDA, EBITDA As Defined, and adjusted net income; a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined, and a reconciliation of earnings per share to adjusted earnings per share for the periods discussed in this press release.
Fiscal 2023 Outlook
- Net sales are anticipated to be in the range of
$5,990 million to$6,190 million compared with$5,429 million in fiscal 2022; - Net income from continuing operations is anticipated to be in the range of
$1,036 million to$1,116 million compared with$866 million in fiscal 2022; - Earnings per share from continuing operations is expected to be in the range of
$17.45 to$18.85 per share based upon weighted average shares outstanding of 57.1 million shares compared with$13.38 per share in fiscal 2022; - EBITDA As Defined is anticipated to be in the range of
$2,995 million to$3,095 million compared with$2,646 million in fiscal 2022 (corresponding to an EBITDA As Defined margin guide of approximately 50% for fiscal 2023); - Adjusted earnings per share is expected to be in the range of
$20.68 to$22.08 per share compared with$17.14 per share in fiscal 2022; and - Fiscal 2023 outlook is based on the following market growth assumptions:
- Commercial aftermarket revenue growth in the mid-teens percentage range;
- Commercial OEM revenue growth in the mid-teens percentage range; and
- Defense revenue growth in the low to mid-single-digit percentage range.
Please see the attached Table 6 for a reconciliation of EBITDA, EBITDA As Defined to net income and reported earnings per share to adjusted earnings per share guidance mid-point estimated for the fiscal year ending
Earnings Conference Call
The call will be archived on the website and available for replay at approximately
About
Non-GAAP Supplemental Information
EBITDA, EBITDA As Defined, EBITDA As Defined Margin, adjusted net income and adjusted earnings per share are non-GAAP financial measures presented in this press release as supplemental disclosures to net income and reported results.
None of EBITDA, EBITDA As Defined, EBITDA As Defined Margin, adjusted net income or adjusted earnings per share is a measurement of financial performance under
Although we use EBITDA and EBITDA As Defined as measures to assess the performance of our business and for the other purposes set forth above, the use of these non-GAAP financial measures as analytical tools has limitations, and you should not consider any of them in isolation, or as a substitute for analysis of our results of operations as reported in accordance with
- neither EBITDA nor EBITDA As Defined reflects the significant interest expense, or the cash requirements, necessary to service interest payments on our indebtedness;
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and neither EBITDA nor EBITDA As Defined reflects any cash requirements for such replacements;
- the omission of the substantial amortization expense associated with our intangible assets further limits the usefulness of EBITDA and EBITDA As Defined;
- neither EBITDA nor EBITDA As Defined includes the payment of taxes, which is a necessary element of our operations; and
- EBITDA As Defined excludes the cash expense we have incurred to integrate acquired businesses into our operations, which is a necessary element of certain of our acquisitions.
Forward-Looking Statements
Statements in this press release that are not historical facts, including statements under the heading "Fiscal 2023 Outlook," are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "may," "will," "should," "expect," "intend," "plan," "predict," "anticipate," "estimate," or "continue" and other words and terms of similar meaning may identify forward-looking statements.
All forward-looking statements involve risks and uncertainties that could cause
Contact: |
Investor Relations |
|
216-706-2945 |
||
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
||||||||
FOR THE THIRTEEN WEEK PERIODS AND FISCAL YEARS ENDED |
Table 1 |
|||||||
|
||||||||
(Amounts in millions, except per share amounts) |
||||||||
(Unaudited) |
||||||||
Thirteen Week Periods Ended |
Fiscal Years Ended |
|||||||
|
|
|
|
|||||
|
$ 1,510 |
$ 1,279 |
$ 5,429 |
$ 4,798 |
||||
COST OF SALES |
625 |
554 |
2,330 |
2,285 |
||||
GROSS PROFIT |
885 |
725 |
3,099 |
2,513 |
||||
SELLING AND ADMINISTRATIVE EXPENSES |
210 |
154 |
748 |
685 |
||||
AMORTIZATION OF INTANGIBLE ASSETS |
34 |
36 |
136 |
137 |
||||
INCOME FROM OPERATIONS |
641 |
535 |
2,215 |
1,691 |
||||
INTEREST EXPENSE—NET |
277 |
261 |
1,076 |
1,059 |
||||
REFINANCING COSTS |
— |
1 |
1 |
37 |
||||
OTHER EXPENSE (INCOME) |
3 |
(14) |
18 |
(51) |
||||
GAIN ON SALE OF BUSINESSES—NET |
(1) |
— |
(7) |
(69) |
||||
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES |
362 |
287 |
1,127 |
715 |
||||
INCOME TAX PROVISION |
96 |
78 |
261 |
34 |
||||
INCOME FROM CONTINUING OPERATIONS |
266 |
209 |
866 |
681 |
||||
INCOME FROM DISCONTINUED OPERATIONS, NET OF TAX |
— |
— |
1 |
— |
||||
NET INCOME |
266 |
209 |
867 |
681 |
||||
LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS |
— |
— |
(1) |
(1) |
||||
NET INCOME ATTRIBUTABLE TO TD GROUP |
$ 266 |
$ 209 |
$ 866 |
$ 680 |
||||
NET INCOME APPLICABLE TO TD GROUP COMMON STOCKHOLDERS |
$ 266 |
$ 209 |
$ 780 |
$ 607 |
||||
Earnings per share attributable to |
||||||||
Earnings per share from continuing operations—basic and diluted |
$ 3.98 |
$ 3.58 |
$ 13.38 |
$ 10.41 |
||||
Earnings per share from discontinued operations—basic and diluted |
— |
— |
0.02 |
— |
||||
Earnings per share |
$ 3.98 |
$ 3.58 |
$ 13.40 |
$ 10.41 |
||||
Cash dividends declared per common share |
$ 18.50 |
$ — |
$ 18.50 |
$ — |
||||
Weighted-average shares outstanding: |
||||||||
Basic and diluted |
56.8 |
58.4 |
58.2 |
58.4 |
|
|||||||||
SUPPLEMENTAL INFORMATION - RECONCILIATION OF EBITDA, |
|||||||||
EBITDA AS DEFINED TO INCOME FROM CONTINUING OPERATIONS |
|||||||||
FOR THE THIRTEEN WEEK PERIODS AND FISCAL YEARS ENDED |
Table 2 |
||||||||
|
|||||||||
(Amounts in millions, except per share amounts) |
|||||||||
(Unaudited) |
|||||||||
Thirteen Week Periods Ended |
Fiscal Years Ended |
||||||||
|
|
|
|
||||||
Income from continuing operations |
$ 266 |
$ 209 |
$ 866 |
$ 681 |
|||||
Adjustments: |
|||||||||
Depreciation and amortization expense |
65 |
65 |
253 |
253 |
|||||
Interest expense, net |
277 |
261 |
1,076 |
1,059 |
|||||
Income tax provision |
96 |
78 |
261 |
34 |
|||||
EBITDA |
704 |
613 |
2,456 |
2,027 |
|||||
Adjustments: |
|||||||||
Acquisition and divestiture transaction-related expenses and adjustments (1) |
5 |
11 |
18 |
35 |
|||||
Non-cash stock and deferred compensation expense (2) |
55 |
23 |
184 |
130 |
|||||
Refinancing costs (3) |
— |
1 |
1 |
37 |
|||||
COVID-19 pandemic restructuring costs (4) |
— |
— |
— |
40 |
|||||
Gain on sale of businesses, net (5) |
(1) |
— |
(7) |
(69) |
|||||
Other, net (6) |
(11) |
(12) |
(6) |
(11) |
|||||
Gross Adjustments to EBITDA |
48 |
23 |
190 |
162 |
|||||
EBITDA As Defined |
$ 752 |
$ 636 |
$ 2,646 |
$ 2,189 |
|||||
EBITDA As Defined, Margin (7) |
49.8 % |
49.7 % |
48.7 % |
45.6 % |
|||||
(1) |
Represents accounting adjustments to inventory associated with acquisitions of businesses and product lines that were charged to cost of sales when inventory was sold; costs incurred to integrate acquired businesses and product lines into |
|
(2) |
Represents the compensation expense recognized by |
|
(3) |
Represents costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements. |
|
(4) |
Represents restructuring costs related to the Company's cost reduction measures in response to the COVID-19 pandemic of |
|
(5) |
Represents the net gain on sale of businesses, which is primarily attributable to the net gain on sale recognized as a result of the divestitures completed during the third quarter of fiscal 2021. |
|
(6) |
Primarily represents foreign currency transaction gain or loss, payroll withholding taxes related to special dividend and dividend equivalent payments and stock option exercises, non-service related pension costs, including the pension settlement charge for the Esterline Retirement Plan, and gain or loss on sale of fixed assets. |
|
(7) |
The EBITDA As Defined margin represents the amount of EBITDA As Defined as a percentage of net sales. |
|
||||||||
SUPPLEMENTAL INFORMATION - RECONCILIATION OF |
||||||||
REPORTED EARNINGS PER SHARE TO |
||||||||
ADJUSTED EARNINGS PER SHARE |
||||||||
FOR THE THIRTEEN WEEK PERIODS AND FISCAL YEARS ENDED |
Table 3 |
|||||||
|
||||||||
(Amounts in millions, except per share amounts) |
||||||||
(Unaudited) |
||||||||
Thirteen Week Periods Ended |
Fiscal Years Ended |
|||||||
|
|
|
|
|||||
Reported Earnings Per Share |
||||||||
Income from continuing operations |
$ 266 |
$ 209 |
$ 866 |
$ 681 |
||||
Less: Net income attributable to noncontrolling interests |
— |
— |
(1) |
(1) |
||||
Net income from continuing operations attributable to TD |
266 |
209 |
865 |
680 |
||||
Less: Dividends paid on participating securities |
(40) |
— |
(86) |
(73) |
||||
Income from discontinued operations, net of tax |
— |
— |
1 |
— |
||||
Net income applicable to |
$ 226 |
$ 209 |
$ 780 |
$ 607 |
||||
Weighted-average shares outstanding under the two-class |
||||||||
Weighted-average common shares outstanding |
54.3 |
55.1 |
54.8 |
54.8 |
||||
Vested options deemed participating securities |
2.5 |
3.3 |
3.4 |
3.6 |
||||
Total shares for basic and diluted earnings per share |
56.8 |
58.4 |
58.2 |
58.4 |
||||
Earnings per share from continuing operations—basic and |
$ 3.98 |
$ 3.58 |
$ 13.38 |
$ 10.41 |
||||
Earnings per share from discontinued operations—basic and |
— |
— |
0.02 |
— |
||||
Earnings per share |
$ 3.98 |
$ 3.58 |
$ 13.40 |
$ 10.41 |
||||
Adjusted Earnings Per Share |
||||||||
Income from continuing operations |
$ 266 |
$ 209 |
$ 866 |
$ 681 |
||||
Gross adjustments to EBITDA |
48 |
23 |
190 |
162 |
||||
Purchase accounting backlog amortization |
1 |
4 |
7 |
11 |
||||
Tax adjustment (1) |
(2) |
12 |
(65) |
(146) |
||||
Adjusted net income |
$ 313 |
$ 248 |
$ 998 |
$ 708 |
||||
Adjusted diluted earnings per share under the two-class |
$ 5.50 |
$ 4.25 |
$ 17.14 |
$ 12.13 |
||||
Diluted Earnings Per Share to Adjusted Earnings Per |
||||||||
Diluted earnings per share from continuing operations |
$ 3.98 |
$ 3.58 |
$ 13.38 |
$ 10.41 |
||||
Adjustments to diluted earnings per share: |
||||||||
Inclusion of the dividend equivalent payments |
0.70 |
— |
1.47 |
1.24 |
||||
Acquisition and divestiture transaction-related expenses and |
0.09 |
0.20 |
0.33 |
0.64 |
||||
Non-cash stock and deferred compensation expense |
0.73 |
0.32 |
2.37 |
1.76 |
||||
Refinancing costs |
— |
0.01 |
0.01 |
0.51 |
||||
Tax adjustment on income from continuing operations |
0.17 |
0.32 |
(0.28) |
(1.90) |
||||
COVID-19 pandemic restructuring costs |
— |
— |
— |
0.54 |
||||
Gain on sale of businesses, net |
(0.01) |
— |
(0.09) |
(0.94) |
||||
Other, net |
(0.16) |
(0.18) |
(0.05) |
(0.13) |
||||
Adjusted earnings per share |
$ 5.50 |
$ 4.25 |
$ 17.14 |
$ 12.13 |
||||
(1) |
For the thirteen week period and fiscal year ended |
|
|||||
SUPPLEMENTAL INFORMATION - RECONCILIATION OF |
|||||
PROVIDED BY OPERATING ACTIVITIES TO EBITDA, |
|||||
EBITDA AS DEFINED |
|||||
FOR THE FISCAL YEARS ENDED |
Table 4 |
||||
|
|||||
(Amounts in millions) |
|||||
(Unaudited) |
|||||
Fiscal Years Ended |
|||||
|
|
||||
Net cash provided by operating activities |
$ 948 |
$ 913 |
|||
Adjustments: |
|||||
Changes in assets and liabilities, net of effects from acquisitions and sales of businesses |
288 |
98 |
|||
Interest expense, net (1) |
1,076 |
1,059 |
|||
Income tax provision - current |
283 |
— |
|||
Loss contract amortization |
39 |
55 |
|||
Non-cash stock and deferred compensation expense (2) |
(184) |
(130) |
|||
Refinancing costs (3) |
(1) |
(37) |
|||
Gain on sale of businesses, net (4) |
7 |
69 |
|||
EBITDA |
2,456 |
2,027 |
|||
Adjustments: |
|||||
Acquisition and divestiture transaction-related expenses and adjustments (5) |
18 |
35 |
|||
Non-cash stock and deferred compensation expense (2) |
184 |
130 |
|||
Refinancing costs (3) |
1 |
37 |
|||
COVID-19 pandemic restructuring costs (6) |
— |
40 |
|||
Gain on sale of businesses, net (4) |
(7) |
(69) |
|||
Other, net (7) |
(6) |
(11) |
|||
EBITDA As Defined |
$ 2,646 |
$ 2,189 |
|||
(1) |
Represents interest expense excluding the amortization of debt issuance costs and premium and discount on debt. |
|
(2) |
Represents the compensation expense recognized by |
|
(3) |
Represents costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements. |
|
(4) |
Represents the net gain on sale of businesses, which is primarily attributable to the net gain on sale recognized as a result of the divestitures completed during the third quarter of fiscal 2021. |
|
(5) |
Represents accounting adjustments to inventory associated with acquisitions of businesses and product lines that were charged to cost of sales when inventory was sold; costs incurred to integrate acquired businesses and product lines into |
|
(6) |
Represents restructuring costs related to the Company's cost reduction measures in response to the COVID-19 pandemic of |
|
(7) |
Primarily represents foreign currency transaction gain or loss, payroll withholding taxes related to special dividend and dividend equivalent payments and stock option exercises, non-service related pension costs, including the pension settlement charge for the Esterline Retirement Plan and gain or loss on sale of fixed assets. |
|
||||
SUPPLEMENTAL INFORMATION - BALANCE SHEET DATA |
Table 5 |
|||
(Amounts in millions) |
||||
(Unaudited) |
||||
|
|
|||
Cash and cash equivalents |
$ 3,001 |
$ 4,787 |
||
Trade accounts receivable—Net |
967 |
791 |
||
Inventories—Net |
1,332 |
1,185 |
||
Current portion of long-term debt |
76 |
277 |
||
Short-term borrowings—trade receivable securitization facility |
350 |
349 |
||
Accounts payable |
279 |
227 |
||
Accrued and other current liabilities |
721 |
810 |
||
Long-term debt |
19,369 |
19,372 |
||
|
(3,773) |
(2,916) |
|
|||
SUPPLEMENTAL INFORMATION - RECONCILIATION OF EBITDA, |
|||
EBITDA AS DEFINED TO NET INCOME AND REPORTED EARNINGS |
|||
PER SHARE TO ADJUSTED EARNINGS PER SHARE GUIDANCE MID-POINT |
|||
FOR THE FISCAL YEAR ENDING |
Table 6 |
||
(Amounts in millions, except per share amounts) |
|||
(Unaudited) |
|||
GUIDANCE MID-POINT |
|||
Fiscal Year Ended |
|||
Net Income |
$ 1,076 |
||
Adjustments: |
|||
Depreciation and amortization expense |
272 |
||
Interest expense - net |
1,140 |
||
Income tax provision - current |
360 |
||
EBITDA |
2,848 |
||
Adjustments: |
|||
Acquisition transaction-related expenses and adjustments (1) |
13 |
||
Non-cash stock and deferred compensation expense (1) |
180 |
||
Other, net (1) |
4 |
||
Gross Adjustments to EBITDA |
197 |
||
EBITDA As Defined |
$ 3,045 |
||
EBITDA As Defined, Margin (1) |
50.0 % |
||
Earnings per share |
$ 18.15 |
||
Adjustments to earnings per share: |
|||
Inclusion of the dividend equivalent payments |
0.69 |
||
Non-cash stock and deferred compensation expense |
2.30 |
||
Acquisition related expenses and adjustments |
0.22 |
||
Other, net |
0.02 |
||
Adjusted earnings per share |
$ 21.38 |
||
Weighted-average shares outstanding |
57.1 |
||
(1) |
Refer to Table 2 above for definitions of Non-GAAP measurement adjustments. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/transdigm-group-reports-fiscal-2022-fourth-quarter-and-year-end-results-301674203.html
SOURCE